Nair Dileep G, Weiskirchen Ralf
Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), Rheinisch-Westfälische Technische Hochschule (RWTH) University Hospital Aachen, D-52074 Aachen, Germany.
Curr Issues Mol Biol. 2023 Dec 29;46(1):262-278. doi: 10.3390/cimb46010018.
Acute and chronic liver diseases cause significant morbidity and mortality worldwide, affecting millions of people. Liver transplantation is the primary intervention method, replacing a non-functional liver with a functional one. However, the field of liver transplantation faces challenges such as donor shortage, postoperative complications, immune rejection, and ethical problems. Consequently, there is an urgent need for alternative therapies that can complement traditional transplantation or serve as an alternative method. In this review, we explore the potential of liver tissue engineering as a supplementary approach to liver transplantation, offering benefits to patients with severe liver dysfunctions.
急慢性肝病在全球范围内导致了严重的发病率和死亡率,影响着数百万人。肝移植是主要的干预方法,用一个有功能的肝脏替换无功能的肝脏。然而,肝移植领域面临着供体短缺、术后并发症、免疫排斥和伦理问题等挑战。因此,迫切需要能够补充传统移植或作为替代方法的替代疗法。在这篇综述中,我们探讨了肝组织工程作为肝移植补充方法的潜力,为严重肝功能障碍患者带来益处。